Clinical impact of antibodies to Sp100 on a bacterial infection in patients with primary biliary cholangitis

BACKGROUND: A specific antinuclear antibody for primary biliary cholangitis (PBC) is anti‐Sp100, which was recognized as a serological marker of concurrent urinary tract infection. We sought to determine the clinical characteristics of PBC patients who had anti‐Sp100. PATIENTS AND METHODS: Fifty‐one...

Descripción completa

Detalles Bibliográficos
Autores principales: Himoto, Takashi, Yamamoto, Shuhei, Morimoto, Kaho, Tada, Satoshi, Mimura, Shima, Fujita, Koji, Tani, Joji, Morishita, Asahiro, Masaki, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605154/
https://www.ncbi.nlm.nih.gov/pubmed/34623692
http://dx.doi.org/10.1002/jcla.24040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605154/
https://www.ncbi.nlm.nih.gov/pubmed/34623692
http://dx.doi.org/10.1002/jcla.24040

Ejemplares similares